Dual-system transvaginal fetal pulse oximetry
Official title: Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
Run by Raydiant Oximetry, Inc. · NCT07296419 · Data updated 2026-11-12
This tests a transvaginal fetal pulse oximetry sensor to collect fetal oxygen saturation and pulse waveforms from women in labor to help develop signal-processing algorithms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 15 (estimated) |
| Sponsor | Raydiant Oximetry, Inc. Industry-sponsored |
| Locations | 1 site (Shreveport, Louisiana) |
| Status | Recruiting |
| Started | December 8, 2025 |
| Main results expected | March 2026 |
| Study ends | April 2026 |
| Registry record updated | December 22, 2025 |
| Trial ID | NCT07296419 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women ≥18 years with singleton, vertex pregnancies at ≥36 weeks in active or latent labor with ruptured membranes, cervical dilation >2 cm and station −2 or lower, Category I–II tracings, and who have epidural anesthesia.
✕Probably not a fit
Patients who are preterm (<36 weeks), have multiple gestations, nonvertex presentation, infections preventing transvaginal monitoring, placenta previa, Category III tracings, or other contraindications are unlikely to benefit and are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study uses the Raydiant Data Collection System to capture red and infrared waveforms from a fetal sensor placed on the cheek, temple, or forehead during labor. Waveforms are post-processed to calculate fetal SpO2 and pulse rate and to support development of signal qualification and data-processing algorithms. Both participants and care teams are blinded to the oximetry displays so routine clinical monitoring guides care, and monitoring is limited to a period not exceeding six hours. The trial enrolls term, singleton, vertex pregnancies with ruptured membranes and established labor at a single site (LSU Health Shreveport) and excludes conditions that preclude transvaginal monitoring or indicate fetal compromise.
Why it matters
Potential benefit: If successful, the technology could give clinicians a reliable fetal SpO2 signal to help detect fetal hypoxia earlier and reduce missed cases of newborn metabolic acidosis.
How similar studies have gone: Prior clinical research with the Nellcor N-400 system showed 92.9% sensitivity and 54.2% positive predictive value for detecting neonatal metabolic acidosis, so the approach has prior supporting evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Willing and capable of providing informed consent. 2. Age \> 18 years. 3. Gestational age \> 36 weeks. 4. Singleton pregnancy. 5. Vertex presentation, 6. In latent or active labor, 7. Category I or II tracings, 8. Epidural anesthesia, and 9. Ruptured amniotic sac with cervical dilation of \>2 cm and a station of -2 or lower. Exclusion Criteria: 1. Age \< 18 years. 2. Gestational age \< 36 weeks 3. Multiple gestation 4. Nonvertex fetal presentation 5. Suspected vasa previa 6. Category III CTG tracing 7. Fetal anomalies and/or chromosomal disorders 8. Chorioamnionitis 9. Placenta previa 10. HIV, genital Herpes, or other infection precluding transvaginal monitoring 11. Unable to provide informed consent (e.g., cognitively impaired) 12. Low anterior placenta, or 13. Any condition (temporary or permanent) in which the investigator deems the patient unsuitable for the study procedures.
Where it's running
-
LSU Health Science Center-Shreveport
Shreveport, Louisiana, United States Recruiting
Study contacts
- Principal investigator: Perry S Barrilleaux, MD — Louisiana State University Health Shreveport
- Study coordinator: Shannon Phillips, RN, BSN
- Email: shannon.phillips@lsuhs.edu
- Phone: 318-675-7207
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital fetal scalp stimulation during labor to identify fetal hypoxia
This trial will see if a brief digital stimulation of the fetal scalp during labor can improve heart-rate tracings and scalp blood results for babies with suspicious or pathological cardiotocography.
-
Keeping the umbilical cord intact during resuscitation after emergency cesarean delivery
This will test whether keeping the umbilical cord attached for 3–5 minutes during resuscitation helps term babies born by emergency C-section who aren't breathing.
-
Oxygen supplementation for mothers during labor to help babies in distress
This study is testing if giving extra oxygen to mothers during labor can help their babies who are in distress feel better and avoid complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.